Regulatory/Legislative News

The time to implement new technology is when it offers clinical value, helps maintain your practice reputation for cutting-edge care or helps you provide patients with a positive experience. But there are important business considerations when evaluating new technology, too. In this two-part article, we address some of the legal and financial issues.

The Affordable Care Act was signed into law 10 years ago today.

Patients will soon have what HHS called “unprecedented” secure and free access to their health information.

SAN FRANCISCO — Ensuring safe and effective products are available to the American people is the mission of the FDA Center for Drug Evaluation and Research, which is why there is a reason behind everything the FDA asks for when studying new drug products, according to a speaker at Glaucoma 360: New Horizons Forum.

Leaders from the FDA and the National Institute on Drug Abuse said during a recent House Committee on Energy and Commerce hearing that there is a pressing need for federal laws that allow more research into marijuana, including research investigating the effects of different amounts of THC.

The CustomFlex artificial iris was granted transitional pass-through payment status from CMS, effective Jan. 1, 2020.

Vyzulta has been approved in Mexico for the reduction of IOP in patients with open-angle glaucoma or ocular hypertension, Nicox announced in a press release.

Twelve ophthalmology leaders have signed a public letter to the U.K. government calling for a national plan to address sight loss, according to a press release from Fight for Sight.

As a new decade begins, Healio.com/OSN looks back at some of our biggest stories in the past 10 years. Over the years, ophthalmology has evolved to include new treatment options, both surgical and pharmaceutical, for numerous conditions affecting every part of the eye.

On Wednesday, the 5th U.S. Circuit Court of Appeals announced that it agreed with a district court that the Affordable Care Act’s individual mandate was unconstitutional, but it sent the case back to the district court for additional analysis.